About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
COVID-19
New Therapies and Current Patient Management of Lymphomas
Update on Patient Care Treatment Strategies in Leukemia
Controversies and Update for Patient Care in Multiple Myeloma
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
S
Penn Update on Lower Risk MDS: How Beneficial Are Lenalidomide, Luspatercept & Imetelstat?
By
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
FEATURING
Shannon McCurdy
By
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
FEATURING
Shannon McCurdy
28 views
March 2, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
24:08
Indy Hematology Review
Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…
Feat.
A. Tefferi
Featured Video
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
Update on Patient Care Treatment Strategies in Leukemia
12:45
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
Anti-CD19 CAR-T for R/R CLL: How Frequent Are MRD- Responses? When D…
Feat.
D. Porter
13:58
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
Penn Medicine Updates on Blood/Marrow Transplantation & Cellular…
Feat.
P. Ford
22:10
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
UPenn Expert Discussion on MDS, MPN & Leukemia: Transfusion-Depe…
Feat.
K. Pratz,
S. McCurdy,
D. Babushok,
A. Perl,
S. Luger,
S. Saroha
18:36
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
2021 Penn Update on AML: How Beneficial Is Ven Addition to Aza in El…
Feat.
A. Perl
21:53
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
2021 Penn Medicine Update on FLT3i in R/R AML: Gilteritinib Mono and…
Feat.
A. Perl
14:03
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
Penn Update on MPNs: Can We Prevent MPNs? Is RopegIFN Effective and …
Feat.
D. Babushok
11:43
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
Penn Update on MPNs: Does PTG-300 Eliminate the Need for Therapeutic…
Feat.
D. Babushok
14:31
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
Penn Updates on CML: Do Cancer-Related Mutational Events at Diagnosi…
Feat.
D. Babushok
11:19
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
Penn Update on Lower Risk MDS: How Beneficial Are Lenalidomide, Lusp…
Feat.
S. McCurdy
20:56
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
Penn Update on Novel Therapies for Higher Risk MDS: What Is the Role…
Feat.
S. McCurdy
